The most commonly reported adverse events, regardless of causality, for Casodex 50 mg plus an LHRH-A, were hot flashes, pain, back pain, asthenia, constipation, pelvic pain, infection, nausea, dyspnea, peripheral edema, diarrhea, hematuria, and nocturia. Serum transaminase levels should be measured prior to starting treatment with Casodex, at regular intervals for the first four months of treatment, and periodically thereafter. One out of every six men is at lifetime risk for prostate cancer. It is the second most frequently occurring malignancy in American men, after skin cancer, and represents 29 percent of all newly diagnosed cancer cases. Every three minutes a man is diagnosed with prostate cancer in the United States and a life is lost to the disease every 13 minutes.
Prostate cancer is the second leading cause of cancer death among men after lung cancer.
According to the American Cancer Society it is estimated that nearly 200,000 new cases will be diagnosed in the United States during 2001. Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer. All rights reserved.